It is encouraging to see the level of current investment and its breadth. With the continuing rise of antimicrobial resistance and implications cutting across all areas of medicine, investments are a necessary foundation for urgently needed progress. The Dynamic Dashboard will help funders in their future funding decisions. Some high-level summary of information from the Dynamic Dashboard can be found here.
18.10.2024
Hub-WHO Joint G7 Progress Report Published
The Hub and WHO have published their annual progress report on activities G7 countries are undertaking to incentivise the development of new antibacterials.